"Micro"-managing the MiRNome in SzS

Blood

Volumn 116, Issue 7, 2010, Pages 1021-1022

  Chng, Wee J ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956550089     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-285189     Document Type: Note

References (7)

1. Ballabio E, Mitchell T, van Kester MS, et al. MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential. Blood. 2010;116(7):1105-1113.
2. Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sezary syndrome. Lancet. 2008;371(9616):945-957.
3. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):127-139.
4. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Cancer. 2009;10(10):704-714.
5. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673-677. (Pubitemid 46676103)
6. Kumar MS, Pester RE, Chen CY, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 2009;23(23):2700-2704.
7. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101(9):2999-3004. (Pubitemid 38327724)